Philips Respironics, Inc. Trilogy EVO Ventilator, France - Model Number: FR2110X14B Trilogy Evo is intended for pediatric through adult patients weighing at least 2.5 kg. The ventilator can measure, display, record, and alarm SpO2, FiO2, CO2, and Pulse Rate data when integrated with the appropriate accessories. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Trilogy EVO Ventilator, France - Model Number: FR2110X14B Trilogy Evo is intended for pediatric through adult patients weighing at least 2.5 kg. The ventilator can measure, display, record, and alarm SpO2, FiO2, CO2, and Pulse Rate data when integrated with the appropriate accessories.
Brand
Philips Respironics, Inc.
Lot Codes / Batch Numbers
Model/Material Number: FR2110X14B Serial Numbers: H248213027F13, H249718745CF4, H252330869C7A, H252331053AFD, H255249974881
Products Sold
Model/Material Number: FR2110X14B Serial Numbers: H248213027F13, H249718745CF4, H252330869C7A, H252331053AFD, H255249974881,
Philips Respironics, Inc. is recalling Trilogy EVO Ventilator, France - Model Number: FR2110X14B Trilogy Evo is intended for pediatric t due to Software defect in the Trilogy EVO and Trilogy EVO Universal Ventilator, versions SW 1.00.05, SW 1.01.09.00, SW 1.01.10.00, and SW 1.01.11.00, causing. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Software defect in the Trilogy EVO and Trilogy EVO Universal Ventilator, versions SW 1.00.05, SW 1.01.09.00, SW 1.01.10.00, and SW 1.01.11.00, causing inoperative and loss of all power alarms. This defect causes an incorrect or unexpected result failing requirements TSRS1298 and PRD439.
Recommended Action
Per FDA guidance
On November 19, 2019 the firm distributed Urgent Medical Device Recall Communication letters by mail stating: URGENT - Field Safety Notice Trilogy Evo, Garbin Evo, LifeVent Evo 2 Released Software Versions SW 1.00.05, SW 1.01.09.00, SW 1.01.10.00, and SW 1.01.11.00 Dear Customer, During engineering testing, Philips became aware of two (2) unlikely scenarios that result in the Trilogy Evo failing to alarm immediately and persistently after a loss of therapy event. The failure to alarm as designed is the result of the software on impacted Trilogy Evo devices not reacting properly to these events. Patients may be at risk should this problem occur while the patient is not being actively monitored. There have been no reports of harm or injury associated with this issue. Affected devices can continue to be used in accordance with this Field Safety Notice. This Field Safety Notice informs you of the following: " Description of the issue and the circumstances under which it can occur " Customer/user actions that are required to prevent risks for patients " Philips Respironics actions to resolve the issue This document contains important information for the continued safe and proper use of your equipment Please review the following information with all members of your staff who need to be aware of the contents of this communication. It is important to understand the implications of this communication. Please retain a copy with the equipment Instruction for Use. Should you have any questions or need further information regarding this communication, please do not hesitate to contact us at 1-724-387-4000 for all international calls. This notice has been reported to the appropriate regulatory agencies. We appreciate your support in reacting to this Field Safety Notice and sincerely regret any inconvenience that this action may cause you. HOW TO IDENTIFY AFFECTED PRODUCTS Affected models include Trilogy Evo, Garbin Evo, LifeVent Evo 2 units with s
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
DE
Page updated: Jan 10, 2026